GPT and metabolic dysfunction-associated steatotic liver disease: Currently, there are several non-invasive diagnostic tools used for the assessment of NAFLD including biochemical markers; alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as non-invasive indicators of NAFLD; as well as histology and imaging modalities (CT, MRI, US).